Arginine limitation causes a directed DNA sequence evolution response in colorectal cancer cells.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
02 Jan 2023
Historique:
pubmed: 31 1 2023
medline: 31 1 2023
entrez: 30 1 2023
Statut: epublish

Résumé

Utilization of specific codons varies significantly across organisms. Cancer represents a model for understanding DNA sequence evolution and could reveal causal factors underlying codon evolution. We found that across human cancer, arginine codons are frequently mutated to other codons. Moreover, arginine restriction-a feature of tumor microenvironments-is sufficient to induce arginine codon-switching mutations in human colon cancer cells. Such DNA codon switching events encode mutant proteins with arginine residue substitutions. Mechanistically, arginine limitation caused rapid reduction of arginine transfer RNAs and the stalling of ribosomes over arginine codons. Such selective pressure against arginine codon translation induced a proteomic shift towards low arginine codon containing genes, including specific amino acid transporters, and caused mutational evolution away from arginine codons-reducing translational bottlenecks that occurred during arginine starvation. Thus, environmental availability of a specific amino acid can influence DNA sequence evolution away from its cognate codons and generate altered proteins.

Identifiants

pubmed: 36711568
doi: 10.1101/2023.01.02.521806
pmc: PMC9881871
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R35 CA274446
Pays : United States

Commentaires et corrections

Type : UpdateIn

Déclaration de conflit d'intérêts

Competing interests: Authors declare that they have no competing interests.

Auteurs

Dennis J Hsu (DJ)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Jenny Gao (J)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Norihiro Yamaguchi (N)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Alexandra Pinzaru (A)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Nandan Mandayam (N)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Maria Liberti (M)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Søren Heissel (S)

Proteomics Resource Center, The Rockefeller University, New York, NY, USA.

Hanan Alwaseem (H)

Proteomics Resource Center, The Rockefeller University, New York, NY, USA.

Saeed Tavazoie (S)

Department of Systems Biology, Columbia University Medical Center, New York, NY, USA.
Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY USA.

Sohail F Tavazoie (SF)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Classifications MeSH